APA (7th ed.) Citation

Z, Z., MA, F., SG, O., J, R., S, Z., S, F., . . . ME, E. (2025). Anti-hypertensive Drug Classes and Risk of New-Onset Atrial Fibrillation in Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial. Drugs & aging, 42(12), 1159. https://doi.org/10.1007/s40266-025-01258-6

Chicago Style (17th ed.) Citation

Z, Zhou, et al. "Anti-hypertensive Drug Classes and Risk of New-Onset Atrial Fibrillation in Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial." Drugs & Aging 42, no. 12 (2025): 1159. https://doi.org/10.1007/s40266-025-01258-6.

MLA (9th ed.) Citation

Z, Zhou, et al. "Anti-hypertensive Drug Classes and Risk of New-Onset Atrial Fibrillation in Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial." Drugs & Aging, vol. 42, no. 12, 2025, p. 1159, https://doi.org/10.1007/s40266-025-01258-6.